Enzyme–Nanoparticle Conjugates for Biomedical Applications

Methods in Molecular Biology

Volumn 679, Issue , 2011, Pages 165-182

  Vertegel, Alexey A ^a   Reukov, Vladimir ^a   Maximov, Victor ^a  

^a AMRL   (United States)

Author keywords

Antibody; Biodegradable nanoparticles; Conjugates; PLGA; Targeted delivery; Therapeutic enzymes

Indexed keywords

ENZYME; LACTIC ACID; LIPOSOME; LYSOZYME; NANOPARTICLE; POLYGLYCOLIC ACID; POLYLACTIC ACID POLYGLYCOLIC ACID COPOLYMER; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; REACTIVE OXYGEN METABOLITE; SILICON DIOXIDE; SUPEROXIDE DISMUTASE;

ARTICLE; BIOMEDICAL ENGINEERING; CHEMICAL STRUCTURE; CHEMISTRY; DRUG DELIVERY SYSTEM; ENZYME THERAPY; FIBRINOLYTIC THERAPY; METABOLISM; METHODOLOGY;

BIOMEDICAL ENGINEERING; DRUG DELIVERY SYSTEMS; ENZYME THERAPY; ENZYMES; LACTIC ACID; LIPOSOMES; MOLECULAR STRUCTURE; MURAMIDASE; NANOPARTICLES; POLYGLYCOLIC ACID; REACTIVE OXYGEN SPECIES; SILICON DIOXIDE; SUPEROXIDE DISMUTASE; THROMBOLYTIC THERAPY;

MLCS; MLOWN;

EID: 79952197794     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-60761-895-9_14     Document Type: Chapter

References (86)

1. S. Mumtaz and B. K. Bachhawat, Enzyme engineering and its application in lysosomal storage disease, Pure and Applied Chemistry 64 (1992), no. 8, 1055–1060.
2. V. P. Torchilin, Drug targeting, European Journal of Pharmaceutical Science 11 (2000), no. 2, S81–S91.
3. Y. Takakura and M. Hashida, Macromolecular carrier systems for targeted drug delivery: Pharmacokinetic considerations on biodistribu-tion, Pharmaceutical Research 13 (1996), no. 6, 820–831.
4. J. Cassidy and A. G. Schätzlein, Tumour-targeted drug and gene delivery: Principles and concepts, Expert Reviews in Molecular Medicine 6 (2004), no. 19, 1–17.
5. B. H. Biela, L. A. Khawli, P. Hu and A. L. Epstein, Chimeric TNT-3/human beta-glucuronidase fusion proteins for antibody-directed enzyme prodrug therapy (ADEPT), Cancer Biotherapy & Radiopharmaceuticals 18 (2003), no. 3, 339–353.
6. W. P. Faulk and G. M. Taylor, Immunocolloid method for electron microscope, Immunochem-istry 8 (1971), no. 11, 1081–1083.
7. M. Lundqvist, I. Sethson and B. H. Jonsson, Protein adsorption onto silica nanoparticles: Conformational changes depend on the parti-cles’ curvature and the protein stability, Langmuir 20 (2004), no. 24, 10639–10647.
8. W. R. Glomm, Functionalized gold nanoparticles for applications in bionanotechnology, Journal of Dispersion Science and Technology 26 (2005), no. 3, 389–414.
9. V. Maximov, V. Reukov and A. Vertegel, Targeted delivery of therapeutic enzymes, Journal of Drug Delivery Science and Technology 19 (2009), no. 5, 311–320.
10. A. V. Elgersma, R. L. J. Zsom, W. Norde and J. Lyklema, The adsorption of bovine serum-albumin on positively and negatively charged polystyrene lattices, Journal of Colloid and Interface Science 138 (1990), no. 1, 145–156.
11. W. J. Parak, D. Gerion, T. Pellegrino, D. Zanchet, C. Micheel, S. C. Williams, R. Boudreau, M. A. Le Gros, C. A. Larabell and A. P. Alivisatos, Biological applications of colloidal nanocrystals, Nanotechnology 14 (2003), no. 7, R15–R27.
12. I. Brigger, C. Dubernet and P. Couvreur, Nanoparticles in cancer therapy and diagnosis, Advanced Drug Delivery Reviews 54 (2002), no. 5, 631–651.
13. J. M. Nam, C. S. Thaxton and C. A. Mirkin, Nanoparticle-based bio-bar codes for the ultrasensitive detection of proteins, Science 301 (2003), no. 5641, 1884–1886.
14. C. M. Niemeyer, Nanoparticles, proteins, and nucleic acids: Biotechnology meets materials science, Angewandte Chemie – International Edition 40 (2001), no. 22, 4128–4158.
15. T. J. Webster, L. S. Schadler, R. W. Siegel and R. Bizios, Mechanisms of enhanced osteoblast adhesion on nanophase alumina involve vit-ronectin, Tissue Engineering 7 (2001), no. 3, 291–301.
16. C. K. Bower, S. Sananikone, M. K. Bothwell and J. McGuire, Activity losses among T4 lysozyme charge variants after adsorption to colloidal silica, Biotechnology and Bioengineering 64 (1999), no. 3, 373–376.
17. C. Czeslik and R. Winter, Effect of temperature on the conformation of lysozyme adsorbed to silica particles, Physical Chemistry Chemical Physics 3 (2001), no. 2, 235–239.
18. A. Kondo, F. Murakami, M. Kawagoe and K. Higashitani, Kinetic and circular-dichroism studies of enzymes adsorbed on ultrafine silica particles, Applied Microbiology and Biotechnology 39 (1993), no. 6, 726–731.
19. W. Norde and A. C. I. Anusiem, Adsorption, desorption and readsorption of proteins on solid-surfaces, Colloids and Surfaces 66 (1992), no. 1, 73–80.
20. D. J. A. Crommelin, G. Storm, W. Jiskoot, R. Stenekes, E. Mastrobattista and W. E. Hennink, Nanotechnological approaches for the delivery of macromolecules, Journal of Controlled Release 87, 2003, no. 1–3, 81–88.
21. K. L. Heredia and H. D. Maynard, Synthesis of protein–polymer conjugates, Organic & Biomolecular Chemistry 5 (2007), no. 1, 45–53.
22. J. Kim, J. W. Grate and P. Wang, Nanostructures for enzyme stabilization, Chemical Engineering Science 61 (2006), no. 3, 1017–1026.
23. A. A. Vertegel, R. W. Siegel and J. S. Dordick, Silica nanoparticle size influences the structure and enzymatic activity of adsorbed lysozyme, Langmuir 20 (2004), no. 16, 6800–6807.
24. P. A. J. Henricks and F. P. Nijkamp, Reactive oxygen species as mediators in asthma, Pulmonary Pharmacology & Therapeutics 14 (2001), no. 6, 409–421.
25. W. Domej, Z. Foldes-Papp, E. Flogel and B. Haditsch, Chronic obstructive pulmonary disease and oxidative stress, Current Pharmaceutical Biotechnology 7 (2006), no. 2, 117–123.
26. E. J. Park and K. Park, Oxidative stress and pro-inflammatory responses induced by silica nanoparticles in vivo and in vitro, Toxicology Letters 184 (2009), no. 1, 18–25.
27. H. S. Park, S. R. Kim and Y. C. Lee, Impact of oxidative stress on lung diseases, Respirology 14 (2009), no. 1, 27–38.
28. I. Rahman, Oxidative stress and gene transcription in asthma and chronic obstructive pulmonary disease: Antioxidant therapeutic targets, Current Drug Targets. Inflammation and Allergy 1 (2002), no. 3, 291–315.
29. J. J. Arcaroli, J. E. Hokanson, E. Abraham, M. Geraci, J. R. Murphy, R. P. Bowler, C. A. Dinarello, L. Silveira, J. Sankoff, D. Heyland, P. Wischmeyer and J. D. Crapo, Extracellular superoxide dismutase haplotypes are associated with acute lung injury and mortality, American Journal of Respiratory and Critical Care Medicine 179 (2009), no. 2, 105–112.
30. C. Vaissiere, V. Le Cabec and I. Maridonneau-Parini, NADPH oxidase is functionally assembled in specific granules during activation of human neutrophils, Journal of Leukocyte Biology 65 (1999), no. 5, 629–634.
31. K. K. Griendling, D. Sorescu and M. Ushio-Fukai, NAD(P)H oxidase – role in cardiovascular biology and disease, Circulation Research 86 (2000), no. 5, 494–501.
32. A. S. Baldwin, The NF-kappa B and I kappa B proteins: New discoveries and insights, Annual Review of Immunology 14 (1996), 649–683.
33. R. Shenkar, M. D. Schwartz, L. S. Terada, J. E. Repine, J. McCord and E. Abraham, Hemorrhage activates NF-kappa B in murine lung mononuclear cells in vivo, American Journal of Physiology – Lung Cellular and Molecular Physiology 270 (1996), no. 5, L729–L735.
34. T. S. Blackwell and J. W. Christman, The role of nuclear factor-kappa B in cytokine gene regulation, American Journal of Respiratory Cell and Molecular Biology 17 (1997), no. 1, 3–9.
35. K. Yasui and A. Baba, Therapeutic potential of superoxide dismutase (SOD) for resolution of inflammation, Inflammation Research 55 (2006), no. 9, 359–363.
36. M. P. Lehucker-Michel, J. F. Lesgards, O. Delubac, P. Stocker, P. Durand and M. Prost, Oxidative stress and human disease: Current knowledge and perspectives for prevention, Presse Médicale 30 (2001), no. 21, 1076–1081.
37. I. Rahman and W. MacNee, Role of oxidants/ antioxidants in smoking-induced lung diseases, Free Radical Biology and Medicine 21 (1996), no. 5, 669–681.
38. M. Nishikawa, M. Kudo, N. Kakemizu, H. Ikeda and T. Okubo, Role of superoxide anions in airway hyperresponsiveness induced by cigarette smoke in conscious guinea pigs, Lung 174 (1996), no. 5, 279–289.
39. M. Tsuchiya, D. F. T. Thompson, Y. J. Suzuki, C. E. Cross and L. Packer, Superoxide formed from cigarette-smoke impairs polymorphonu-clear leukocyte active oxygen generation activity, Archives of Biochemistry and Biophysics 299 (1992), no. 1, 30–37.
40. K. Ito and P. J. Barnes, COPD as a disease of accelerated lung aging, Chest 135 (2009), no. 1, 173–180.
41. W. A. Pryor, Cigarette smoke and the involvement of free radical reactions in chemical car-cinogenesis, British Journal of Cancer. Supplement 55 (1987), no. VIII, 19–23.
42. D. F. Church and W. A. Pryor, Free-radical chemistry of cigarette-smoke and its toxicological implications, Environmental Health Perspectives 64 (1985), 111–126.
43. W. A. Pryor and S. S. Godber, Oxidative stress status – an introduction, Free Radical Biology and Medicine 10 (1991), no. 3–4, 173–173.
44. T. Nakayama, D. F. Church and W. A. Pryor, Quantitative-analysis of the hydrogen-peroxide formed in aqueous cigarette tar extracts, Free Radical Biology and Medicine 7 (1989), no. 1, 9–15.
45. T. Nakayama, M. Kodama and C. Nagata, Generation of hydrogen-peroxide and superoxide anion radical from cigarette-smoke, Gann 75 (1984), no. 2, 95–98.
46. M. Nishikawa, N. Kakemizu, T. Ito, M. Kudo, T. Kaneko, M. Suzuki, N. Udaka, H. Ikeda and T. Okubo, Superoxide mediates cigarette smoke-induced infiltration of neutrophils into the airways through nuclear factor-kappa b activation and IL-8 mRNA expression in guinea pigs in vivo, American Journal of Respiratory Cell and Molecular Biology 20 (1999), no. 2, 189–198.
47. A. H. Assa’ad, E. T. Ballard, K. D. Sebastian, D. P. Loven, G. P. Boivin and M. B. Lierl, Effect of superoxide dismutase on a rabbit model of chronic allergic asthma, Annals of Allergy Asthma & Immunology 80 (1998), no. 3, 215–224.
48. A. Garcia-Gonzalez, J. Herrera-Abarca and J. L. Ochoa, Effect of superoxide dismutase from bovine erythrocytes on different activity parameters in adjuvant-induced arthritis, Archives of Medical Research 30 (1999), no. 2, 132–137.
49. N. Skorohod and D. B. Yeates, Superoxide dismutase failed to attenuate allergen-induced nasal congestion in ragweed-sensitized dogs, Journal of Applied Physiology 98 (2005), no. 4, 1478–1486.
50. S. Das, S. Horowitz, C. G. Robbins, M. E. El-Sabban, N. Sahgal and J. M. Davis, Intracellular uptake of recombinant superoxide dismutase after intratracheal administration, American Journal of Physiology – Lung Cellular and Molecular Physiology 274 (1998), no. 5, L673–L677.
51. E. G. Langenback, J. M. Davis, C. Robbins, N. Sahgal, R. J. Perry and S. R. Simon, Improved pulmonary distribution of recombinant human Cu/Zn superoxide dismutase, using a modified ultrasonic nebulizer, Pediatric Pulmonology 27 (1999), no. 2, 124–129.
52. S. Giovagnoli, P. Blasi, M. Ricci and C. Rossi, Biodegradable microspheres as carriers for native superoxide dismutase and catalase delivery, AAPS Pharmscitech 5 (2004), no. 4, e51.
53. S. Giovagnoli, G. Luca, I. Casaburi, P. Blasi, G. Macchiarulo, M. Ricci, M. Calvitti, G. Basta, R. Calafiore and C. Rossi, Long-term delivery of superoxide dismutase and catalase entrapped in poly(lactide-co-glycolide) microspheres: In vitro effects on isolated neonatal porcine pancreatic cell clusters, Journal of Controlled Release 107 (2005), no. 1, 65–77.
54. L. A. Dailey, N. Jekel, L. Fink, T. Gessler, T. Schmehl, M. Wittmar, T. Kissel and W. Seeger, Investigation of the proinflammatory potential of biodegradable nanoparticle drug delivery systems in the lung, Toxicology and Applied Pharmacology 215 (2006), no. 1, 100–108.
55. S. Lee, S. C. Yang, M. J. Heffernan, W. R. Taylor and N. Murthy, Polyketal microparticles: A new delivery vehicle for superoxide dismutase, Bioconjugate Chemistry 18 (2007), no. 1, 4–7.
56. M. C. Gongora, H. E. Lob, U. Landmesser, T. J. Guzik, W. D. Martin, K. Ozumi, S. M. Wall, D. S. Wilson, N. Murthy, M. Gravanis, T. Fukai and D. G. Harrison, Loss of extracellular superoxide dismutase leads to acute lung damage in the presence of ambient air – a potential mechanism underlying adult respiratory distress syndrome, American Journal of Pathology 173 (2008), no. 4, 915–926.
57. M. K. Reddy, L. Wu, W. Kou, A. Ghorpade and V. Labhasetwar, Superoxide dismutase-loaded PLGA nanoparticles protect cultured human neurons under oxidative stress, Applied Biochemistry and Biotechnology 151 (2008), no. 2–3, 565–577.
58. M. K. Reddy and V. Labhasetwar, Nanoparticle-mediated delivery of superoxide dismutase to the brain: An effective strategy to reduce ischemia-reperfusion injury, FASEB Journal 23 (2009), no. 5, 1384–1395.
59. D. J. Begley, Delivery of therapeutic agents to the central nervous system: The problems and the possibilities, Pharmacology & Therapeutics 104 (2004), no. 1, 29–45.
60. U. Schroeder, P. Sommerfeld, S. Ulrich and B. A. Sabel, Nanoparticle technology for delivery of drugs across the blood–brain barrier, Journal of Pharmaceutical Sciences 87 (1998), no. 11, 1305–1307.
61. V. Reukov, J. Olbrich, R. Satishkumar and A. Vertegel, Protein–nanoparticle conjugates as a potential therapeutic agents for treatment of secondary spinal cord injury, Proceedings of the MRS 2007 Fall Meeting, Materials Research Society, 2007, 6–16.
62. J. I. Weitz, R. J. Stewart and J. C. Fredenburgh, Mechanism of action of plasminogen activators, Thrombosis and Haemostasis 82 (1999), no. 2, 974–982.
63. E. Haber, T. Quertermous, G. R. Matsueda and M. S. Runge, Innovative approaches to plasminogen-activator therapy, Science 243 (1989), no. 4887, 51–56.
64. K. Huber, M. S. Runge, C. Bode and D. Gulba, Thrombolytic therapy in acute myocar-dial infarction – update 1996, Annals of Hematology 73 (1996), S29–S38.
65. N. M. Orekhova, R. S. Akchurin, A. A. Belyaev, M. D. Smirnov, S. E. Ragimov and A. N. Orekhov, Local prevention of thrombosis in animal arteries by means of magnetic targeting of aspirin-loaded red-cells, Thrombosis Research 57 (1990), no. 4, 611–616.
66. C. F. Driscoll, R. M. Morris, A. E. Senyei, K. J. Widder and G. S. Heller, Magnetic targeting of microspheres in blood-flow, Microvascular Research 27 (1984), no. 3, 353–369.
67. V. P. Torchilin, M. I. Papisov and V. N. Smirnov, Magnetic sephadex as a carrier for enzyme immobilization and drug targeting, Journal of Biomedical Materials Research 19 (1985), no. 4, 461–466.
68. C. Alexiou, W. Arnold, P. Hulin, R. J. Klein, H. Renz, F. G. Parak, C. Bergemann and A. S. Lubbe, Magnetic mitoxantrone nanoparticle detection by histology, X-ray and MRI after magnetic tumor targeting, Journal of Magnetism and Magnetic Materials 225 (2001), 187–193.
69. Y. H. Ma, Y. W. Hsu, Y. J. Chang, M. Y. Hua, J. P. Chen and T. Wu, Intra-arterial application of magnetic nanoparticles for targeted thrombolytic therapy: A rat embolic model, Journal of Magnetism and Magnetic Materials 311 (2007), no. 1, 342–346.
70. G. Gregoriadis, A. T. Florence and H. M. Patel, Liposomes in drug delivery, Harwood Academic Publishers, Langhorne, PA (1993).
71. G. Gregoriadis, Liposome technology, CRC Press, Boca Raton, FL, 1–3, 2nd ed. (1993).
72. S. D. Tiukinhoy-Laing, S. L. Huang, M. Klegerman, C. K. Holland and D. D. McPherson, Ultrasound-facilitated thromboly-sis using tissue-plasminogen activator-loaded echogenic liposomes, Thrombosis Research 119 (2007), no. 6, 777–784.
73. Y. Yurko, V. Maximov, E. Andreozzi, G. L. Thompson and A. A. Vertegel, Design of biomedical nanodevices for dissolution of blood clots, Materials Science & Engineering: C (Materials for Biological Applications) 29 (2009), no. 3, 737–741.
74. M. L. Fernandez Guerrero, J. M. Ramos, J. Marrero, M. Cuenca, R. Fernandez Roblas and M. De Gorgolas, Bacteremic pneumococcal infections in immunocompromised patients without AIDS: The impact of beta-lactam resistance on mortality, International Journal of Infectious Diseases 7 (2003), no. 1, 46–52.
75. M. Zaiou, Multifunctional antimicrobial peptides: Therapeutic targets in several human diseases, Journal of Molecular Medicine 85 (2007), no. 4, 317–329.
76. F. Niyonsaba and H. Ogawa, Protective roles of the skin against infection: Implication of naturally occurring human antimicrobial agents beta-defensins, cathelicidin LL-37 and lysozyme, Journal of Dermatological Science 40 (2005), no. 3, 157–168.
77. J. Kreuter and P. P. Speiser, New adjuvants on a polymethylmethacrylate base, Infection and Immunity 13 (1976), no. 1, 204–210.
78. S. Henrymichelland, M. J. Alonso, A. Andremont, P. Maincen, J. Sauzieres and P. Couvreur, Attachment of antibiotics to nanoparticles-preparation, drug-release and antimicrobial activity in vitro, International Journal of Pharmaceutics 35 (1987), no. 1–2, 121–127.
79. M. E. Page-Clisson, H. Pinto-Alphandary, E. Chachaty, P. Couvreur and A. Andremont, Drug targeting by polyalkylcyanoacrylate is not efficient against persistent salmonella, Pharmaceutical Research 15 (1998), no. 4, 544–549.
80. F. Esmaeili, M. Hosseini-Nasr, M. Rad-Malekshahi, N. Samadi, F. Atyabi and R. Dinarvand, Preparation and antibacterial activity evaluation of rifampicin-loaded poly lactide-co-glycolide nanoparticles, Nanomedicine – Nanotechnology Biology and Medicine 3 (2007), no. 2, 161–167.
81. 2 anti-solvent precipitation for sustained antimicrobial activity, International Journal of Pharmaceutics 287 (2004), no. 12, 163–173.
82. L. W. Qu, P. G. Luo, S. Taylor, Y. Lin, W. J. Huang, N. Anyadike, T. R. J. Tzeng, F. Stutzenberger, R. A. Latour and Y. P. Sun, Visualizing adhesion-induced agglutination of Escherichia coli with mannosylated nanoparticles, Journal of Nanoscience and Nanotechnology 5 (2005), no. 2, 319–322.
83. P. J. G. Luo, T. R. Tzeng, L. W. Qu, Y. Lin, E. Caldwell, R. A. Latou, F. Stutzenberger and Y. P. Sun, Quantitative analysis of bacterial aggregation mediated by bioactive nanoparticles, Journal of Biomedical Nanotechnology 1 (2005), no. 3, 291–296.
84. L. W. Qu, L. R. Gu, H. P. Li, S. Taylor, T. Elkin, P. J. G. Luo, T. R. J. Tzeng, X. P. Jiang, R. A. Latour, F. Stutzenberger, A. Williams and Y. P. Sun, Galactosylated polymeric nanoparticles: Synthesis and adhesion interactions with Escherichia coli, Journal of Biomedical Nanotechnology 1 (2005), no. 1, 61–67.
85. H. Yang, L. W. Qu, A. Wimbrow, X. P. Jiang and Y. P. Sun, Enhancing antimicrobial activity of lysozyme against Listeria monocy-togenes using immunonanoparticles, Journal of Food Protection 70 (2007), no. 8, 1844–1849.
86. R. Satishkumar and A. Vertegel, Charge-directed targeting of antimicrobial protein– nanoparticle conjugates, Biotechnology and Bioengineering 100 (2008), no. 3, 403–412.